1. Introduction {#sec1-molecules-25-00160}
===============

*Morinda officinalis (M. officinalis)* and *Morinda citrifolia* (*M. citrifolia*) belong to the family Rubiaceae \[[@B1-molecules-25-00160]\]. The roots of *M. officinalis* have long been used ass traditional medicine for the strengthening of bones and immunity, and the nourishment of the kidneys \[[@B2-molecules-25-00160]\]. It has also been used to treat impotence, osteoporosis, depression and inflammatory diseases, such as rheumatoid arthritis and dermatitis \[[@B2-molecules-25-00160]\]. Moreover, the clinical effects of *M. officinalis* have been proved by modern pharmacological studies \[[@B3-molecules-25-00160],[@B4-molecules-25-00160],[@B5-molecules-25-00160],[@B6-molecules-25-00160]\]. The fruit of *M. citrifolia* is also called Noni in Hawaii and the juice made of it has been used as alternative medicine for arthritis, high blood pressure, diabetes, mental depression, sprains, and muscle aches \[[@B7-molecules-25-00160],[@B8-molecules-25-00160],[@B9-molecules-25-00160]\]. The *M. citrifolia* fruit extract has been shown to exhibit antimicrobial, antifungal, antioxidant, anti-arthritic, and anticancer activities \[[@B10-molecules-25-00160],[@B11-molecules-25-00160]\]. Furthermore, it also shows anxiolytic and sedative activities, and immunity enhancing activity \[[@B12-molecules-25-00160],[@B13-molecules-25-00160]\]. *M. officinalis* and *M. citrifolia* were commonly distributed in the south of China (Guangdong, Guangxi and Hainan province) and are named as "HAIBAJI" and "BAJITIAN". In Hainan province, both plants are surprisingly called BAJI, and their roots have been used as edible herbal plants to treat sexual impotence, spermatorrhea, irregular menstruation, and female infertility \[[@B14-molecules-25-00160]\]. However, evidence for such uses remains elusive, although both plants contain anthraquinones and iridoid glycosides \[[@B1-molecules-25-00160],[@B15-molecules-25-00160]\]. In this study, we aim to determine whether the roots of the two plants have the same active chemical constituents in terms of their pharmaceutical functions. Quadrupole time-of-flight mass spectrometry (Q/TOF-MS) coupled with Ultra-performance liquid chromatography (UPLC) can be comprehensively used to analyze unknown compounds in an organism \[[@B16-molecules-25-00160]\]. Hence, this study examines the principal chemical constituents of the roots of both species using UPLC/QTOF-MS coupled with a multivariate statistical analysis, and subsequently the maker components were elucidated by a principal component analysis (PCA).

2. Results and Discussion {#sec2-molecules-25-00160}
=========================

2.1. Identifying the Chemical Constituents of Morinda officinalis (M. officinalis) and Morinda citrifolia (M. citrifolia) Based on UPLC/Q-TOF-MS/MS {#sec2dot1-molecules-25-00160}
---------------------------------------------------------------------------------------------------------------------------------------------------

The total ion chromatogram (TIC) in the negative ion mode of *M. officinalis* and *M. citrifolia* root extracts is illustrated in [Figure 1](#molecules-25-00160-f001){ref-type="fig"}. The information of identified compounds is summarized in [Table 1](#molecules-25-00160-t001){ref-type="table"}. Compounds **1**--**8** were identified as iridoid glycosides, and their structures are displayed in [Figure 2](#molecules-25-00160-f002){ref-type="fig"}. Generally, this class of compounds underwent a loss of a glucose unit (162) to yield a fragment (M-162) and a subsequent elimination of 44 (CO~2~) and/or 28 (CO) could occur after the loss of glucose unit (Compounds **1** and **3**). Compounds **5**, **6**, and **8** easily gave fragment ions of a glucoside (180), C~2~H~2~O (42), and COOH (45) produced from the deprotonated ion \[[@B17-molecules-25-00160],[@B18-molecules-25-00160],[@B19-molecules-25-00160]\]. The proposed fragmentation pathway is shown in [Figure S1](#app1-molecules-25-00160){ref-type="app"}.

Compounds **9**--**36**, **38**--**44**, **46**--**47**, **49**, **51**, **56** were characterized as anthraquinones, and their structures are displayed in [Figure 3](#molecules-25-00160-f003){ref-type="fig"}. Based on whether they had a glycosyl group, the compounds were further classified into either anthraquinone glycosides (**9**--**36**, **41**) or anthraquinone aglycones (**38**--**40**, **42**--**44**, **46**--**47**, **49**, **51**, **56**). The parent ions of anthraquinone glycosides yielded fragment ions by effortlessly losing a glucose unit (162), xyloside unit (132), CH~2~ (14), and HCOOH (46) \[[@B17-molecules-25-00160],[@B18-molecules-25-00160],[@B19-molecules-25-00160]\]. The proposed fragmentation pathway is shown in [Figure S2](#app1-molecules-25-00160){ref-type="app"}. By contrast, anthraquinone aglycones were relatively stable, thus their fragments were difficult to determine.

Compounds **37**, **45**, **48**, **50**, **52**--**55**, **57**--**63** were determined as triterpenes, and their structures are displayed in [Figure 4](#molecules-25-00160-f004){ref-type="fig"} \[[@B20-molecules-25-00160]\]. The structure of triterpenes is relatively stable, and it commonly formed ions that were produced by the loss of a unit of H~2~O. To date, approximately 100 compounds have been isolated from *M. officinalis,* which mainly are polysaccharides, oligosaccharides, anthraquinones, triterpenes, and iridoid glycosides \[[@B2-molecules-25-00160]\]. Approximately, 160 compounds have been isolated and identified from *M. citrifolia,* which mainly comprise anthraquinones, organic acids, alkaloid, terpenes and volatile compounds \[[@B11-molecules-25-00160]\]. In the present study, 49 compounds from the methanol extract of *M. officinalis* roots were identified, classified into 26 anthraquinones, 15 triterpenes, and 8 iridoid glycosides. At the same time, 39 compounds were identified from the methanol extract of *M. citrifolia* roots, including 30 anthraquinones, 1 triterpene, and 8 iridoid glycosides. Among them, 25 compounds were found to be present in both plants. These compounds are classified into 16 anthraquinones, 1 triterpene, and 8 iridoid glycosides. Detailed information on the identified compounds is shown in [Table 1](#molecules-25-00160-t001){ref-type="table"}.

2.2. Tentative Identification of Potential Marker Compounds from M. officinalis and M. citrifolia {#sec2dot2-molecules-25-00160}
-------------------------------------------------------------------------------------------------

To clarify the compound differences between the methanol extracts of *M. officinalis* and *M. citrifolia* roots, an untargeted metabolite profiling of the extracts was conducted and analyzed by UPLC-QTOF-MS/MS and Progenesis QI software. The PCA scores plot ([Figure 5](#molecules-25-00160-f005){ref-type="fig"}A) indicates that the chemical compositions of *M. officinalis* and *M. citrifolia* differ from one another. *M. officinalis* and *M. citrifolia* root samples were clearly distinguished by the principal component 1 (PC1). Furthermore, to explore the potential biomarkers corresponding to the differences between *M. officinalis* and *M. citrifolia* root extracts, UPLC-QTOF-MS/MS data were processed by a supervised OPLS-DA. Through an S-plot analysis at each point, the X- and *Y*-axis showed the variable contributions and sample correlations. The compounds with significant differences between groups were called marker compounds, and were plotted at the top right (1) and bottom left (-1). Therefore, nine ions (red box mark) were selected as candidates, to chemically distinguish *M. officinalis* from *M. citrifolia* root extracts ([Figure 5](#molecules-25-00160-f005){ref-type="fig"}B).

The variable importance in projection (VIP) plot ([Figure 5](#molecules-25-00160-f005){ref-type="fig"}C) showed that all the 7 selected potential marker compounds in *M. citrifolia* root extracts and 2 selected potential marker compounds in *M. officinalis* root extract have a high VIP value (VIP \> 3), suggesting that these marker compounds are largely responsible for the chemical difference between these two samples. Furthermore, the variable average between groups clearly showed content discrepancy of the selected marker compounds in *M. citrifolia* and *M. officinalis* root extracts ([Figure 5](#molecules-25-00160-f005){ref-type="fig"}D). The 9 selected markers were asperulosidic acid (**6**), 1-*O*-gentiobiose-2-methylol-anthraquinone (**11**), 1-*O*-primeverose-aloe-emodin (**15**), 1-*O*-gentiobiose-3-hydroxy-2-methyl- anthraquinone (**20**), 3-*O*-primeverose-1,8-dihydroxy-2-methyl-anthraquinone (**26**), 1-methyl-3-hydroxy-anthraquinone (**40**), rubiadin (**41**), emodin (**43**), and 2,3,19,23-tetrahydroxyolean-12-en-28-oic acid (**50**). The results showed that the levels of 3-*O*-primeverose-1,8-dihydroxy-2-methyl-anthraquinone (**26**) and 2,3,19,23-tetrahydroxyolean-12-en-28-oic acid (**50**) were relatively higher in the root extract of *M. officinalis*, than in *M. citrifolia* ([Figure 5](#molecules-25-00160-f005){ref-type="fig"}D). The other seven compounds were relatively higher in *M. citrifolia* roots. Among them, compounds **11**, **15,** and **40** are anthraquinones, which are the characteristic compounds of the family Rubiaceae. Asperulosidic acid (**6,** iridoid glucosides) is one of the most common pharmacologically active ingredients in *M. officinalis* \[[@B2-molecules-25-00160]\]. Previous reports found that it exhibited anti-inflammatory, anti-renal fibrosis, and antibacterial activities \[[@B21-molecules-25-00160],[@B22-molecules-25-00160]\].

2.3. The Cytotoxicity of the Methanol Extracts of M. officinalis and M. citrifolia Roots {#sec2dot3-molecules-25-00160}
----------------------------------------------------------------------------------------

To further investigate the differences in the methanol extracts of *M. officinalis* and *M. citrifolia* roots in terms of cytotoxicity, a CCK-8 assay was used to examine the cell viability of three liver cell lines (normal cells: LO2; cancer cells: HepG2, SMMCH771) after treatment by *M. officinalis* and *M. citrifolia* root extracts. As shown in [Figure 6](#molecules-25-00160-f006){ref-type="fig"}A, the two extracts were non-cytotoxic to the cells after a treatment of 24 h at concentrations of up to 100 μg/mL. When treated for 48 and 72 h, lower cell viability was observed in *M. citrifolia root extract* treatment groups compared to *M. officinalis root extract* treatment groups. In addition, a colony formation assay was used to evaluate the long-term impact of the *M. officinalis* and *M. citrifolia* root extracts on the cells. The results showed that a high dose of *M. officinalis* and *M. citrifolia* root extracts promoted the cell proliferation of LO2 cells, and inhibited the cell proliferation of HepG2 and SMMCH771 cells ([Figure 6](#molecules-25-00160-f006){ref-type="fig"}B). No significant differences were found between the root extracts of *M. officinalis* and *M. citrifolia* in terms of long-term impact on HepG2 and SMMCH771 cells. Hence, it is suggested that the methanol extracts of *M. officinalis* and *M. citrifolia* roots showed no cell cytotoxicity to normal cells, and even promoted the proliferation of normal liver cells. Meanwhile, compared to *M. officinalis root* extract, *M. citrifolia* root extracts exhibited stronger cell cytotoxicity to liver cancer cells.

Numerous studies indicated that *M. citrifolia* extracts exhibited anticancer activity \[[@B23-molecules-25-00160]\]. For instance, the leaf extract of *M. citrifolia* has an inhibitory effect on lung cancer through strengthening immune response \[[@B24-molecules-25-00160]\]. Its fruit extracts induced apoptosis and suppressed migration in human liver and breast cancer cells \[[@B25-molecules-25-00160]\]. In contrast, few publications report the antitumor activity of *M. officinalis.* Our results are consistent with previous reports that *M. officinalis* root extracts show poor cell cytotoxicity toward cancer cells, compared with *M. citrifolia* root extracts.

3. Materials and Methods {#sec3-molecules-25-00160}
========================

3.1. Instruments and Materials {#sec3dot1-molecules-25-00160}
------------------------------

A Waters ACQUITY UPLC (Milford, MA, USA) coupled to a Xevo G2-XS Q-Tof (Milford, MA, USA) mass spectrometer was utilized. The ACQUITY UPLC HSS T3 RP-18 column (100 × 2.1 mm, 1.8 μm) was purchased from Waters (Milford, MA, USA). Masslynx V4.1, UNIFI^®^ and Progenesis QI were also from Waters (Milford, MA, USA). A precision scale (Secura513-1CN) was used (Sartorius Corporation, Germany).

Pall GHPAcrodisc^®^ Syringe filters (0.2 μm, 13 mm) were purchased from Pall (Pensacola, FL, USA). Disposable sterilized syringes (1 mL) and needles were purchased from Fenglin Medical Apparatus Corporation Ltd. (Jiangxi, China). Pipette tips (1000 μL, 200 μL and 20 μL) were purchased from Labmed Biotech Corporation (USA). Centrifuge tubes were from KiRGEN (Atlanta, GA, USA). Vials (1.5 mL and 2 mL) were purchased from Waters (Milford, MA, USA).

HPLC-grade methanol, acetonitrile, and water were from Fisher (Pittsburgh, PA, USA). Formic acid (LC/MS grade) was purchased from Merck Millipore (Darmstadt, Germany). ACS grade sodium hydroxide was obtained from Sigma-Aldrich (St. Louis, MO, USA). Distilled water was purchased from Watsons (Guangzhou, China). Lastly, ultrapure water was obtained through Milli-Q purification system (Merck Millipore, Darmstadt, Germany). Other solvents and reagents used were of analytical grade.

3.2. Plant Materials {#sec3dot2-molecules-25-00160}
--------------------

The roots of *M. officinalis* (How.) and *M. citrifolia* (Linn.) were collected from the germplasm repository of tropical medicinal plants, Danzhou City, Ministry of Agriculture, Hainan Province, China, in November and December 2018. *M. officinalis* (How.) was introduced from Diaoluoshan, Lingshui Li Autonomous Count, Hainan Province, China. *M. citrifolia* (Linn.) was introduced from Xisha yongxing island, Hainan Province, China.

The identification of the voucher specimens was authenticated by Maoyuan Wang from the Tropical Crops Genetic Resources Institute, Chinese Academy of Tropical Agricultural Sciences. Specimens were then deposited in the Key Laboratory of Crop Gene Resources and Germplasm Enhancement in Southern China, Ministry of Agriculture, Hainan Haikou, China (No. B20181121 and B20181208). The plant materials were air-dried and ground for the extraction procedure.

3.3. Sample Preparation {#sec3dot3-molecules-25-00160}
-----------------------

The air-dried roots of *M. officinalis* and *M. citrifolia* were ground and passed through an 80-mesh sieve. Each powdered sample (1.0 g) was mixed with methanol (50 mL) and then sonicated for 1 h at a temperature of 40 °C. The extract was subjected to centrifugation (12,000 rpm, 10 °C) for 10 min. The supernatant was passed through a 0.2 μm polytetrafluoroethylene (PTFE) syringe filter (VWR Bridgeport, PA, USA) and transferred to a 2 mL transparent vial \[[@B19-molecules-25-00160]\].

3.4. UPLC/Q-TOF-MS Detection Conditions {#sec3dot4-molecules-25-00160}
---------------------------------------

### 3.4.1. Chromatographic Conditions {#sec3dot4dot1-molecules-25-00160}

The separation was conducted on a Waters ACQUITY UPLC system with an ACQUITY UPLC HSS T3 C18 column and 0.1% aqueous formic acid (A) and acetonitrile with 0.1% formic acid (B) was applied as the solvent system. The flow rate was 0.3 mL/min, and each sample solution was injected 1 μL. The column temperature was controlled at 40 °C. Five injections each were performed for both, sample and the blank control. A linear gradient elution was used as follows: 0--4 min, 3--15% B; 4--12 min, 15--60% B; 12--16 min, 60--80% B; 16--18 min, 80--100% B; 18--21 min, 100--100% B; 21--22 min, 100--3% B; 22--25 min, 3--3% B.

### 3.4.2. Mass Spectometry Conditions {#sec3dot4dot2-molecules-25-00160}

A Waters Xevo G2 QTOF equipped with Z-Spray electro spray ionization (ESI) source and MassLynx 4.1 was used for MS data acquisition. Negative ionization mode was applied to acquire data under a mass range of 50−1200 Da with a scan time of 0.2 s and detection time of 22 min; furthermore, both low-energy (function 1) and high-energy (function 2) scan functions were used. The collision energy was 6 V for the low-energy scan function, and 10--45 V for the high-energy scan function. The capillary voltages were set at 2.0 kV, and the sampling cone voltage at 40 V. The source and desolvation temperatures were 100 °C and 400 °C, respectively. The desolvation gas flow rate was 600 L/h, while the cone gas flow rate was 50 L/h.

3.5. Mass Data Processing and Analysis {#sec3dot5-molecules-25-00160}
--------------------------------------

Progenesis QI software was utilized to convert the data of UPLC/Q-TOF-MS, i.e.,; then, the significant differential retention time-exact mass (RT-EM) pairs in the S-plots were picked and exported back into Progenesis QI for compound structural elucidation. The resultant data matrices were subsequently exported to EZinfo 2.0 software (MassLynx v4.1, Waters) for PCA (principal component analysis) and an orthogonal partial least squares-discriminant analysis (OPLS-DA) to examine differences in the samples. All variables obtained from UPLC-MS datasets were mean-centered and scaled to Pareto variance before subjection to PCA and OPLS-DA. The OPLS-DA score plots were depicted by the cross-validation parameter R2Y and Q2, which signify the total explained variation for the X matrix and the predictability of the model, respectively. The sum of squares of the PLS weights was evaluated by the value of VIP (variable importance in projection), showing the relative contribution of each X variable in the model. The variables with VIP \>3 were considered influential for the separation of samples in the score plots from the PLS-DA analysis \[[@B26-molecules-25-00160],[@B27-molecules-25-00160]\].

3.6. Chemical Composition and Biomarker Identification {#sec3dot6-molecules-25-00160}
------------------------------------------------------

Multiple approaches were applied to identify chemical components and biomarkers, which include; comparison with retention times, accurate molecular ions, and characteristic fragment ions of reference compounds; reported data of the same compounds in the literature; online Traditional Chinese Medicine (TCM) Chinese \[UNIFI1.7\]; and ChemSpider \[[@B27-molecules-25-00160]\].

3.7. Cell Viability Assay {#sec3dot7-molecules-25-00160}
-------------------------

Cells were planted into 96-well plates. Various concentrations of the extracts (0.4, 1.2, 3.7, 11.1, 33.3 and 100 μg/mL) were added into the culture media for 24 h, 48 h, and 72 h. At 1 h before each time point, a 10 μL volume of CCK-8 reagent was added to each well. Optical density values at 450 nm were read with a microplate reader (Elx808, Bio Tek, Winooski, VT, USA) and analyzed with GraphPad Prism 7.0 software (GraphPad, San Diego, CA, USA).

3.8. Cell Colony Formation Assay {#sec3dot8-molecules-25-00160}
--------------------------------

Cells were plated into 12-well plates in a triplicate manner. The root extracts of *M. officinalis* and *M. citrifolia* (25, 50, and 100 μg/mL) were added to the plates. Culture media were replaced every third day. After 10 days, the culture medium was discarded, and cells were washed by phosphate-buffered saline (PBS). Then, cells were fixed with 4% paraformaldehyde (Beyotime Biotechnology, Shanghai, China) for 30 min, and stained with crystal violet (Beyotime) for 30 min, followed by a wash with distilled water. The colonies were imaged by a HP scanner and counted under an inverted phase contrast microscope.

3.9. Data Analysis {#sec3dot9-molecules-25-00160}
------------------

Cell experiments were performed in triplicate, and the results are presented as the mean value ± standard error of the mean (SEM). Data were analyzed using GraphPad Prism 7.0 software (GraphPad, San Diego, CA, USA), and p \< 0.05 was considered statistically significant.

4. Conclusions {#sec4-molecules-25-00160}
==============

In the present study, a total of 49 compounds were identified from the methanol extract of the root of *M. officinalis* and 39 compounds were identified from the methanol extract of the root of *M. citrifolia* by a UPLC-QTOF-MS/MS analysis. We found 25 ingredients that were present in both plants; they consisted of anthraquinones, triterpene, and iridoid glycosides. Using a QI analysis, we identified 9 components that could be used as chemical markers to distinguish the root extracts of *M. officinalis* from those of *M. citrifolia* introduced from Hainan Province. In addition, we found that *M. officinalis* and *M. citrifolia* exhibited no cell cytotoxicity towards normal cells, and even promoted the proliferation of normal liver cells. Our study suggests that *M. officinalis* and *M. citrifolia roots* have similarities in terms of chemical composition and biological activity. However, further research is needed to explore the feasibility and substitutability of the clinical application of *M. officinalis* and *M. citrifolia*.

**Sample Availability:** Samples of the compounds of *Morinda officinalis* and *Morinda citrifolia* are available from the authors.
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Click here for additional data file.

The following are available online. Figure S1: The propose fragmentation pathways of anthraquinones; Figure S2: The propose fragmentation pathways of anthraquinones.
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![The total ion chromatogram (TIC) in the negative ion mode of samples: A for methanol extract of roots of *M. officinalis* roots, B for methanol extract *M. citrifoli* roots.](molecules-25-00160-g001){#molecules-25-00160-f001}
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![Chemical structures of triterpenoids identified in *M. citrifolia* and *M. officinalis.*](molecules-25-00160-g004){#molecules-25-00160-f004}

![Selected potential biomarkers from *M. officinalis* and *M. citrifolia* based on principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA). (**A**) PCA score plot; (**B**) S-Plot from OPLS-DA of *M. officinalis* and *M. citrifolia*. (**C**) The variable importance in projection (VIP) score of selected markers; (**D**) Butterfly shows the variable averages by group of selected potential marker compounds. The most differential compounds are marked with a red square.](molecules-25-00160-g005){#molecules-25-00160-f005}

![The effect of *M. officinalis* and *M. citrifolia* root extracts on cell growth. (**A**) Cell viability was evaluated by a CCK-8 assay kit. \* *p* \< 0.05, compared to 24 h treatment group. (**B**) The colony formation ability of cells was detected through a colony formation assay. \* *p* \< 0.05, \*\* *p* \< 0.01, compared with untreated cells. M.C: the methanol extract from *M. citrifolia* root. M.O: the methanol extract from *M. officinalis* root.](molecules-25-00160-g006){#molecules-25-00160-f006}
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###### 

The mass spectrometry data and identified chemical compounds from *M. officinalis* and *M. citrifolia.*

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Peak\   Rt^e^ (min)   Formula           Quasi-Molecular Ion        MS^2^ Ions   Molecular Weight   Mass\         Identification   Type                                                                                       Source       
  No.                                                                                                Error (ppm)                                                                                                                            
  ------- ------------- ----------------- -------------------------- ------------ ------------------ ------------- ---------------- ------------------------------------------------------------------------------------------ -------- --- ---
  1       1.76          C~16~H~22~O~11~   389.1087 \[M − H\]^−^      209.0457\    390.1159           390.1162      −0.7             monotropein                                                                                I        √   √
                                                                     137.0610                                                                                                                                                               

  2       2.30          C~16~H~22~O~11~   389.1089 \[M − H\]^−^      \-           390.1162           390.1162      −0.1             diacetylasperulosidic acid                                                                 I        √   √

  3       3.03          C~16~H~22~O~10~   419.1191 \[M + HCOO\]^−^   211.0613\    374.1209           374.1213      −1.0             geniposidic acid                                                                           I        √   √
                                                                     123.0454                                                                                                                                                               

  4       3.17          C~18~H~24~O~12~   477.1248 \[M + HCOO\]^−^   417.1039\    432.1266           432.1268      −0.4             isoasperulosidic acid                                                                      I        √   √
                                                                     371.0983\                                                                                                                                                              
                                                                     209.0453\                                                                                                                                                              
                                                                     191.0350\                                                                                                                                                              
                                                                     165.0559\                                                                                                                                                              
                                                                     161.0248\                                                                                                                                                              
                                                                     147.0454                                                                                                                                                               

  5       3.67          C~17~H~26~O~11~   451.1454 \[M+HCOO\]^−^     243.0875     406.1472           406.1475      −0.8             harpagide acetate                                                                          I        √   √

  6       4.10          C~18~H~24~O~12~   431.1196 \[M − H\]^−^      371.0974\    432.1269           432.1268      0.3              asperulosidic acid                                                                         I        √   √
                                                                     251.0563\                                                                                                                                                              
                                                                     165.0560                                                                                                                                                               

  7       4.78          C~21~H~32~O~15~   523.1666 \[M − H\]^−^      477.1613\    524.1739           524.1741      −0.4             rehmannioside A                                                                            I        √   √
                                                                     293.0876\                                                                                                                                                              
                                                                     233.0669                                                                                                                                                               

  8       4.86          C~18~H~22~O~11~   459.1143 \[M + HCOO\]^−^   147.0454     414.1161           414.1162      −0.3             asperuloside                                                                               I        √   √

  9       6.44          C~26~H~28~O~15~   579.1342 \[M − H\]^−^      413.1078\    580.1415           580.1428      −2.4             3-*O*-primeverose-1,6,8-trihydroxy-2-methyl-anthraquinone                                  A            √
                                                                     285.0398\                                                                                                                                                              
                                                                     146.9650                                                                                                                                                               

  10      6.84          C~27~H~30~O~15~   593.1507 \[M − H\]^−^      253.0506     594.1580           594.1585      −0.8             1-*O*-primeverose-3-methoxy-8-hydroxy-2-methylol-anthraquinone                             A        √   √

  11      6.89          C~27~H~30~O~14~   623.1616 \[M + HCOO\]^−^   283.0612\    578.1634           578.1636      −0.2             1-*O*-gentiobiose-2-methylol-anthraquinone                                                 A        √   √
                                                                     253.0506\                                                                                                                                                              
                                                                     146.9654                                                                                                                                                               

  12      7.21          C~22~H~22~O~10~   491.1195 \[M + HCOO\]^−^   283.0613     446.1213           446.1213      −0.1             1-*O*-β-[d]{.smallcaps}-glycopyranosyl-8-methoxy-emodin                                    A            √

  13      7.23          C~28~H~32~O~14~   637.1771 \[M + HCOO\]^−^   547.1449\    592.1789           592.1792      −0.4             1-*O*-primeverose-3,8-dimethoxy-2-methyl-anthraquinone                                     A            √
                                                                     307.0609\                                                                                                                                                              
                                                                     297.0763\                                                                                                                                                              
                                                                     283.0613                                                                                                                                                               

  14      7.25          C~27~H~30~O~15~   593.1510 \[M − H\]^−^      269.0456\    594.1583           594.1585      −0.3             1-*O*-gentiobiose-emodin                                                                   A        √   
                                                                     251.0350\                                                                                                                                                              
                                                                     146.9655                                                                                                                                                               

  15      7.27          C~26~H~28~O~14~   563.1405 \[M − H\]^−^      269.0457\    564.1478           564.1479      −0.2             1-*O*-primeverose-aloeemodin                                                               A        √   √
                                                                     251.0352\                                                                                                                                                              
                                                                     237.0557                                                                                                                                                               

  16      7.34          C~27~H~30~O~14~   577.1561 \[M − H\]^−^      253.0504     578.1634           578.1636      −0.3             3-*O*-gentiobiose -1-hydroxy-2-methyl-anthraquinone                                        A        √   √

  17      7.40          C~27~H~30~O~14~   623.1617\[M + HCOO\]^−^    269.0455     578.1635           578.1636      −0.1             8−*O*-primeverose-1-methoxy-3-hydroxy-2- methyl -anthraquinone                             A        √   

  18      7.53          C~27~H~30~O~14~   577.1559 \[M − H\]^−^      283.0619     578.1632           578.1636      −0.7             3-*O*-primeverose-8-methoxy-1-hydroxy- 2- methyl -anthraquinone                            A        √   

  19      7.57          C~26~H~28~O~14~   609.1461 \[M + HCOO\]^−^   415.1024\    564.1479           564.1479      0.0              8-*O*-primeverose-1,3-dihydroxy-2-methyl -anthraquinone                                    A        √   
                                                                     269.0457                                                                                                                                                               

  20      7.61          C~27~H~30~O~13~   607.1663 \[M + HCOO\]^−^   253.0505     562.1681           562.1686      −0.8             1-*O*-gentiobiose -3-hydroxy- 2-methyl -anthraquinone                                      A        √   √

  21      7.65          C~21~H~20~O~10~   431.0977 \[M − H\]^−^      269.0455\    432.1049           432.1057      −1.7             emodin 1-*O*-β-[d]{.smallcaps}-glycopyranosyl                                              A            √
                                                                     251.0347                                                                                                                                                               

  22      7.74          C~26~H~28~O~14~   563.1404 \[M − H\]^−^      269.0456\    564.1477           564.1479      −0.4             1-*O*-primeverose-3,8-dihydroxy-2-methyl -anthraquinone                                    A        √   √
                                                                     251.0348\                                                                                                                                                              
                                                                     223.0407                                                                                                                                                               

  23      7.75          C~28~H~32~O~15~   607.1665 \[M − H\]^−^      563.1403\    608.1738           608.1741      −0.6             1-*O*-gentiobiose-8-methoxy-aloeemodin                                                     A            √
                                                                     283.0617\                                                                                                                                                              
                                                                     267.0661\                                                                                                                                                              
                                                                     251.0348                                                                                                                                                               

  24      7.80          C~27~H~30~O~14~   577.1556 \[M − H\]^−^      283.0618     578.1629           578.1636      −1.2             1-*O*-primeverose-8-methoxy-3-hydroxy-2-methyl-anthraquinone                               A        √   

  25      7.87          C~27~H~30~O~15~   639.1558 \[M + HCOO\]^−^   299.0562     594.1576           594.1585      −1.3             1-*O*-primeverose-3,4-dimethoxy-2-hydroxy-anthraquinone                                    A        √   

  26      7.89          C~26~H~28~O~14~   563.1405 \[M − H\]^−^      269.0457     564.1478           564.1479      −0.2             3-*O*-primeverose-1,8-dihydroxy-2-methyl -anthraquinone                                    A        √   

  27      7.93          C~27~H~30~O~15~   593.1502 \[M − H\]^−^      547.1452\    594.1574           594.1585      −1.7             1-*O*-primeverose-2- methylol-3-hydroxy-8-methoxy-anthraquinone                            A            √
                                                                     283.0608\                                                                                                                                                              
                                                                     285.0405\                                                                                                                                                              
                                                                     251.0347                                                                                                                                                               

  28      8.08          C~22~H~22~O~9~    475.1243 \[M + HCOO\]^−^   267.0658\    430.1261           430.1264      −0.5             1-*O*-β-[d]{.smallcaps}-glycopyranosylrubiadin3-methyl ether                               A            √
                                                                     253.0506                                                                                                                                                               

  29      8.10          C~26~H~28~O~13~   547.1451 \[M − H\]^−^      253.0506     548.1524           548.1530      −1.1             1-*O*-primeverose-2-methylol-anthraquinone                                                 A            √

  30      8.15          C~21~H~20~O~10~   431.0977 \[M−H\]^−^        269.0456     432.1050           432.1057      −1.5             1-*O*-β-[d]{.smallcaps}-glycopyranosyl-emodin                                              A            √

  31      8.25          C~27~H~30~O~15~   593.1514 \[M − H\]^−^      269.0457\    594.1587           594.1585      0.4              1-*O*-gentiobiose-emodin                                                                   A        √   √
                                                                     265.0501                                                                                                                                                               

  32      8.37          C~28~H~32~O~15~   653.1720 \[M + HCOO\]^−^   313.0717\    608.1738           608.1741      −0.6             1-*O*-primeverose-8-hydroxy-ibericin                                                       A            √
                                                                     298.0478                                                                                                                                                               

  33      8.40          C~27~H~30~O~15~   593.1512 \[M − H\]^−^      547.1455\    594.1585           594.1585      0.1              8-*O*-gentiobiose-emodin                                                                   A        √   √
                                                                     431.0981\                                                                                                                                                              
                                                                     269.0455                                                                                                                                                               

  34      8.59          C~26~H~28~O~13~   593.1513 \[M + HCOO\]^−^   253.0508\    548.1531           548.1530      0.2              1-*O*-primeverose-rubiadin                                                                 A        √   √
                                                                     146.9655                                                                                                                                                               

  35      8.67          C~26~H~28~O~14~   563.1407 \[M − H\]^−^      \-           564.1479           564.1479      0.0              1-*O*-primeverose-emodin                                                                   A        √   √

  36      8.81          C~26~H~28~O~15~   579.1353 \[M − H\]^−^      285.0403     580.1426           580.1428      −0.4             1-O-primeverose-2-methyl-3,6,8-trihydroxy-anthraquinone                                    A            √

  37      8.84          C~30~H~48~O~7~    519.3323 \[M − H\]^−^      489.3215     520.3396           520.3400      −0.8             (3α)-3,19,20,24,30-pentahydroxyurs-12-en-28-oic acid                                       T        √   

  38      8.98          C~15~H~10~O~4~    253.0509 \[M − H\]^−^      223.0402     254.0582           254.0579      1.1              1-hydroxy-2-methylol-anthraquinone                                                         A        √   √

  39      9.00          C~15~H~10~O~5~    269.0457 \[M − H\]^−^      \-           270.0530           270.0528      0.5              aloe-emodin                                                                                A            √

  40      9.07          C~15~H~10~O~3~    283.0614 \[M + HCOO\]^−^   \-           238.0632           238.0630      0.9              1-methyl-3-hydroxy-anthraquinone                                                           A        √   √

  41      9.08          C~15~H~10~O~4~    253.0510 \[M − H\]^−^      \-           254.0582           254.0579      1.3              rubiadin                                                                                   A        √   √

  42      9.79          C~19~H~16~O~7~    401.0877 \[M + HCOO\]^-^   283.0607\    356.0895           356.0896      −0.3             fridamycin E                                                                               A        √   √
                                                                     269.0452                                                                                                                                                               

  43      10.07         C~15~H~10~O~5~    269.0458 \[M − H\]^−^      251.0353     270.0531           270.0528      0.9              emodin                                                                                     A        √   √

  44      10.27         C~15~H~10~O~4~    253.0511 \[M − H\]^−^      238.0275     254.0584           254.0579      1.8              3-hydroxy-2-methylol-anthraquinone                                                         A        √   

  45      10.46         C~30~H~46~O~6~    501.3222 \[M − H\]^−^      483.3111\    502.3295           502.3294      0.1              (3α,19β)-3,19,23-trihydroxy-6-oxoolean-12-en-28-oic acid                                   T        √   
                                                                     457.3323                                                                                                                                                               

  46      10.53         C~15~H~10~O~3~    283.0614 \[M + HCOO\]^−^   \-           238.0632           238.0630      0.7              1-hydroxy-2-methyl-anthraquinone                                                           A            √

  47      10.82         C~15~H~10~O~5~    269.0457 \[M − H\]^−^      \-           270.0530           270.0528      0.6              1,3-dihydroxy-2-methoxy-anthraquinone                                                      A            √

  48      10.97         C~30~H~48~O~6~    549.3426 \[M + HCOO\]^-^   485.3259     504.3444           504.3451      −1.2             2,3,6,23-tetrahydroxyurs-12-en-28-oic acid                                                 T        √   

  49      11.00         C~16~H~12~O~4~    267.0658 \[M − H\]^-^      252.0424\    268.0731           268.0736      −1.7             rubiadin 3-methyl ether                                                                    A        √   
                                                                     224.0470                                                                                                                                                               

  50      11.06         C~30~H~48~O~6~    503.3377 \[M − H\]^-^      485.3268     504.3449           504.3451      −0.3             2,3,19,23-tetrahydroxyolean-12-en-28-oic acid                                              T        √   

  51      11.14         C~16~H~12~O~4~    267.0665 \[M − H\]^-^      224.0476     268.0738           268.0736      0.7              rubiadin 1-methyl ether                                                                    A        √   √

  52      11.97         C~30~H~48~O~5~    487.3424 \[M − H\]^-^      469.3322\    488.3497           488.3502      −1.0             (3β,6α)-3,6,24-trihydroxyolean-12-en-28-oic acid                                           T        √   
                                                                     437.3048                                                                                                                                                               

  53      12.26         C~30~H~48~O~5~    485.3273 \[M − H\]^-^      467.3164\    486.3346           486.3345      0.2              (3β,6α)-3,6,23-trihydroxyursa-12,19(29)-dien-28-oic acid                                   T        √   
                                                                     441.3372\                                                                                                                                                              
                                                                     423.3266                                                                                                                                                               

  54      12.91         C~30~H~48~O~5~    487.3433 \[M − H\]^-^      469.3324\    488.3506           488.3502      0.9              (2α,3β,19α)-2,3,19-trihydroxyolean-12-en-28-oic acid                                       T        √   
                                                                     443.3528\                                                                                                                                                              
                                                                     425.3422                                                                                                                                                               

  55      13.01         C~30~H~48~O~5~    487.3429 \[M − H\]^-^      441.3368\    488.3501           488.3502      −0.1             (2α,3α)-2,3,24-trihydroxyolean-18-en-28-oic acid                                           T        √   
                                                                     425.3424\                                                                                                                                                              
                                                                     409.3109                                                                                                                                                               

  56      13.06         C~17~H~14~O~5~    297.0766 \[M − H\]^-^      251.0348     298.0839           298.08412     −0.8             ibericin                                                                                   A        √   

  57      13.11         C~30~H~48~O~5~    487.3425 \[M − H\]^-^      441.3368\    488.3498           488.3502      −0.8             (3α)-3,19,23-trihydroxyurs-12-en-28-oic acid                                               T        √   
                                                                     425.3424\                                                                                                                                                              
                                                                     409.3109                                                                                                                                                               

  58      13.26         C~30~H~48~O~5~    533.3475 \[M+HCOO\]^-^     441.3364     488.3493           488.3502      −1.7             2,3,23-trihydroxyurs-12-en-28-oic acid                                                     T        √   

  59      13.53         C~33~H~50~O~8~    573.3427 \[M − H\]^-^      \-           574.3499           574.3506      −1.1             butyl (3β,7β,12β)-12-acetoxy-3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oate   T        √   

  60      14.30         C~31~H~50~O~6~    517.3527 \[M − H\]^-^      471.3470     518.3600           518.3607      −1.4             (1α,3β,9β)-24-hydroperoxy-1,3-dihydroxy-5-methyl-9,19-cyclolanost-25-en-28-oic acid        T        √   

  61      14.61         C~30~H~48~O~4~    471.3474 \[M − H\]^-^      453.3369\    472.3547           472.3553      −1.2             hederagenin                                                                                T        √   
                                                                     427.3583                                                                                                                                                               

  62      15.95         C~30~H~48~O~4~    517.3528 \[M + HCOO\]^-^   423.3266     472.3546           472.3553      −1.3             maslinic acid                                                                              T        √   

  63      19.52         C~29~H~44~O~2~    423.3264 \[M − H\]^-^      325.0718     424.3337           424.3341      −1.1             camphoratin H                                                                              T        √   √
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

I: iridoid glycosides; A: anthraquinones; T: triterpenes. M. O: *M. officinalis; M. C: M. citrifolia.*
